Pfizer COVID-19 pill PAXLOVOID has now been approved.

The first COVID-19 treatment pill has now been approved by the US health regulators this Wednesday.

The drug is made available by the big pharmaceutical company Pfizer, to help people battle the coronavirus pandemic.

This breakthrough is long awaited and is coming at a time when the US health care system is drawing from the overwhelming cases of the virus infection.

Many deaths are recorded on a daily basis and the hospitalizations rate is going off the roof.

More so, health officials are already warning of the forecasted catastrophic infection rate of the new Omicron variant in the coming weeks.

The novel COVID-19 drug is known as Paxlovid and it is expected to bring about a faster treatment to an early stage COVID-19 infections.

Even though all other drugs against the virus is either in IV form or Injections, this one is simply going to be a pill that you can pop and swallow before going out for the day.

However, the supply is expected is still expected to be limited and will be restricted to certain patients for a start.

Although other pharmaceutical companies like Merck are also expected to win an authorization for it’s antiviral pill soon, the one from Pfizer is still looking more preferable.

The Pfizer COVID-19 pill is said to have up to 90% reduction rate in hospitalization and less death from infected persons and so it is more effective and has a mild side effect.

According to Dr. Gregory Poland of Mayo Clinic ” … efficacy is high, the side effects are low and it’s oral. It checks all the boxes. You’re looking at a 90% decreased risk of hospitalization and death in a high-risk group — that’s stunning.”

The Pfizer drug has been approved by the FDA for adults and children who are 12 years and above and also for older people who test positive for the vitus and run a risk of hospitalization.

Also to be considered are people with underlining health challenges like obesity and heart disease.

More so, children who must take the drug has to be at least 88lb/40kg in weight

The Pfizer and also Merck pills are expected to also be effective against the Omicron variant too.

Pfizer is currently in agreement with the US government to supply treatment for 10 million people and also UK, Australia and some other countries has already signed agreements to also get some supplies.

Currently the company has 180,000 treatment available and close to 70000 has been allocated to the US alone and the remaining will be going to the other parts of the world.

The company also boasts that by next year 2022, that it will up it’s production to about 80 million and also halve its production time from nine months to four and half.

It’s also important to to note that the Paxlovoid drug has only shown effectiveness when administered within five days of COVID-19 symptoms appearing.

And so for now the Pfizer drug will only be prescribed for person who have tested positive for the COVID-19 test.

What do you think?

Social Media Auto Publish Powered By :